Here, we show that BCC treatment drives adaptations in the eCB system by regulating FAAH and CB1 mRNA levels by 12 h followed by a delayed upregulation of CB1 total and surface protein by 48 h. This evidence concerns the gene FAAH and skin basal cell carcinoma.